USA - NYSE:RZB - US7593518027
The current stock price of RZB is 24.99 USD. In the past month the price increased by 0.44%. In the past year, price increased by 0.24%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| RGA | REINSURANCE GROUP OF AMERICA | 8.55 | 12.29B | ||
| RZC | REINSURANCE GRP OF AMER - RGA 7 1/8 10/15/52 | 1.19 | 1.71B |
Reinsurance Group of America, Inc. is a holding company, which engages in the provision of traditional and non-traditional life and health reinsurance products. The company is headquartered in Chesterfield Missouri, Missouri and currently employs 4,100 full-time employees. The firm is a provider of traditional life and health reinsurance and financial solutions. The U.S. and Latin America Traditional segment provides individual and group life and health reinsurance, including long-term care, to domestic clients for a variety of products. The Canada Traditional segment is primarily engaged in individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. The Europe, Middle East and Africa Traditional segment provides individual and group life and health products through yearly renewable term and coinsurance agreements, and reinsurance of critical illness coverage. The Asia Pacific Traditional segment provides individual and group life and health reinsurance, critical illness coverage, disability and superannuation through yearly renewable term and coinsurance agreements.
REINSURANCE GRP OF AMER - RGA 5 3/4 06/15/56
16600 Swingley Ridge Road
Chesterfield Missouri MISSOURI US
Employees: 4100
Phone: 16367367000
Reinsurance Group of America, Inc. is a holding company, which engages in the provision of traditional and non-traditional life and health reinsurance products. The company is headquartered in Chesterfield Missouri, Missouri and currently employs 4,100 full-time employees. The firm is a provider of traditional life and health reinsurance and financial solutions. The U.S. and Latin America Traditional segment provides individual and group life and health reinsurance, including long-term care, to domestic clients for a variety of products. The Canada Traditional segment is primarily engaged in individual life reinsurance, and to a lesser extent creditor, group life and health, critical illness and disability reinsurance. The Europe, Middle East and Africa Traditional segment provides individual and group life and health products through yearly renewable term and coinsurance agreements, and reinsurance of critical illness coverage. The Asia Pacific Traditional segment provides individual and group life and health reinsurance, critical illness coverage, disability and superannuation through yearly renewable term and coinsurance agreements.
The current stock price of RZB is 24.99 USD. The price decreased by -0.12% in the last trading session.
REINSURANCE GRP OF AMER - RGA 5 3/4 06/15/56 (RZB) has a dividend yield of 1.95%. The yearly dividend amount is currently 3.48.
RZB has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
REINSURANCE GRP OF AMER - RGA 5 3/4 06/15/56 (RZB) operates in the Financials sector and the Insurance industry.
REINSURANCE GRP OF AMER - RGA 5 3/4 06/15/56 (RZB) has a market capitalization of 1.65B USD. This makes RZB a Small Cap stock.
REINSURANCE GRP OF AMER - RGA 5 3/4 06/15/56 (RZB) will report earnings on 2026-02-04, after the market close.
ChartMill assigns a technical rating of 7 / 10 to RZB. When comparing the yearly performance of all stocks, RZB turns out to be only a medium performer in the overall market: it outperformed 40.79% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to RZB. RZB may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months RZB reported a non-GAAP Earnings per Share(EPS) of 21.74. The EPS decreased by -2.77% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.54% | ||
| ROA | 0.58% | ||
| ROE | 6.39% | ||
| Debt/Equity | 0.48 |
15 analysts have analysed RZB and the average price target is 32.3 USD. This implies a price increase of 29.24% is expected in the next year compared to the current price of 24.99.
For the next year, analysts expect an EPS growth of -3.8% and a revenue growth 2.94% for RZB